| Financial Year |
March 31 2023 |
| Monetary Funds |
6,523,000,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,000,000.00 |
| Accounts Receivable |
3,859,000,000.00 |
| Advances to Suppliers |
5,179,000,000.00 |
| Other Receivables |
71,000,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
14,411,000,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
589,000,000.00 |
| Total Current Assets |
32,098,000,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,258,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
47,001,000,000.00 |
| Under-construction Projects |
6,763,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,518,000,000.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
1,640,000,000.00 |
| Other Non-Current Assets |
1,102,000,000.00 |
| Sub-Total of Non-Current Assets |
67,682,000,000.00 |
| Total Assets |
99,780,000,000.00 |
| Short-Term Loans |
1,529,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,433,000,000.00 |
| Accounts Payable |
9,244,000,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
232,000,000.00 |
| Taxes Payable |
225,000,000.00 |
| Interest Payable |
3,000,000.00 |
| Dividend Payable |
3,000,000.00 |
| Other payables |
2,496,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,993,000,000.00 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
38,004,000,000.00 |
| Long-term Loans |
1,790,000,000.00 |
| Bonds Payable |
299,000,000.00 |
| Long-Term Accounts Payable |
119,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
149,000,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,094,000,000.00 |
| Total Liabilities |
41,098,000,000.00 |
| Paid-In Capital(Or Share Stock) |
9,401,000,000.00 |
| Capital Surplus |
33,878,000,000.00 |
| Surplus Reserve |
4,457,000,000.00 |
| LESS:Treasury Stock |
92,000,000.00 |
| Undistributed Profits |
10,103,000,000.00 |
| Minority Stockholder's Interest |
662,000,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
58,020,000,000.00 |
| Owner's Equity（Stockholder's Equity） |
58,682,000,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
99,780,000,000.00 |
